Rx Import-For-Export Is Among Issues Holding Up Bioterrorism/PDUFA Bill
Executive Summary
Rx import controls are among the remaining issues that need to be reconciled in the bioterrorism/Prescription Drug User Fee Act conference legislation to complete a consensus bill by Memorial Day
You may also be interested in...
Bioterrorism Antitrust Relief Is One Of Last Major Obstacles To Consensus Bill
Antitrust exemptions for pharmaceutical companies who produce bioterrorism countermeasures is one of the last significant obstacles to moving an anti-bioterrorism authorization bill this year
FDA Developing Proposed Rule For Export Of Investigational New Drugs
FDA is developing a proposed rule to address the export of drugs and biologics for investigational use
Rx Import Controls Included In Tauzin/Dingell Bioterrorism Bill
The House Energy & Commerce Committee bioterrorism bill would increase controls on the importation of pharmaceuticals